Atria Wealth Solutions Inc. has invested $250,000 in Bio-Techne Co. (NASDAQ:TECH).
Bio-Techne is going to present at the
BofA Securities Health Care Conference 2024. The corporation is in the midst of a growth path, reporting positive Q3 2024 Earnings. The
shares of Bio-Techne could be 25% above their intrinsic value estimate.
Amalgamated Bank, First Horizon Advisors Inc., First Trust Direct Indexing L.P., Cwm LLC and GAMMA Investing LLC have also made significant investments. Moreover, there has been a significant short interest hike in Bio-Techne Corporation shares suggesting potential bullish trend.
Bio-Techne has entered into a new distribution agreement with
Thermo Fisher Scientific and a partnership with
Nikon Instruments Inc.. The company's peer-reviewed publications citing RNAscope Technology have surpassed 10,000 and they have filed a patent lawsuit against Molecular Instruments. On the downside, the company has slightly missed EPS by 36%, but analysts forecast a 7.6% EPS beat in the future.
Bio-Techne Corp TECH News Analytics from Thu, 04 Aug 2022 07:00:00 GMT to Fri, 10 May 2024 12:26:13 GMT -
Rating 7
- Innovation 8
- Information 9
- Rumor -1
